Allergic Asthma Global Clinical Trials Review, H1, 2017

GlobalData
158 Pages - GLDATA62945
$2,500.00

Summary

GlobalData's clinical trial report, “Allergic Asthma Global Clinical Trials Review, H1, 2017" provides an overview of Allergic Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies Mentioned

Novartis AG
F. Hoffmann-La Roche Ltd
AstraZeneca Plc
GlaxoSmithKline Plc
Merck KGaA
Merck & Co Inc
Laboratorios LETI SL
ALK-Abello A/S
Quintiles IMS Holdings Inc
Kuros Biosciences AG

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Allergic Asthma to Respiratory Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Allergic Asthma to Respiratory Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Allergic Asthma Therapeutics Clinical Trials 29
Prominent Drugs 31
Latest Clinical Trials News on Allergic Asthma 32
Feb 27, 2017: ALKs ACARIZAX Data Results in Significant Change to the GINA Asthma Management Strategy 32
Clinical Trial Profile Snapshots 33
Appendix 156
Abbreviations 156
Definitions 156
Research Methodology 157
Secondary Research 157
About GlobalData 158
Contact Us 158
Source 158

List of Tables
Allergic Asthma Therapeutics, Global, Clinical Trials by Region, 2017* 6
Allergic Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Allergic Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Allergic Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Allergic Asthma Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Allergic Asthma Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Allergic Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
Allergic Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14
Proportion of Allergic Asthma to Respiratory Clinical Trials, G7 Countries (%), 2017* 15
Allergic Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Allergic Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Allergic Asthma to Respiratory Clinical Trials, E7 Countries (%), 2017* 18
Allergic Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Allergic Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Allergic Asthma Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Allergic Asthma Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Allergic Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Allergic Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Allergic Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Allergic Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Allergic Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Allergic Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
Allergic Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31

List of Figures
Allergic Asthma Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Allergic Asthma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Allergic Asthma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Allergic Asthma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Allergic Asthma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Allergic Asthma Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Allergic Asthma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
Allergic Asthma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14
Proportion of Allergic Asthma to Respiratory Clinical Trials, G7 Countries (%), 2017* 15
Allergic Asthma Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Allergic Asthma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Allergic Asthma to Respiratory Clinical Trials, E7 Countries (%), 2017* 18
Allergic Asthma Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Allergic Asthma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Allergic Asthma Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Allergic Asthma Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Allergic Asthma Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Allergic Asthma Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Allergic Asthma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Allergic Asthma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Allergic Asthma Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Allergic Asthma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Allergic Asthma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31
GlobalData Methodology 157

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports